FDA advisers vote today on approving Galleri, the first multi-cancer blood test, detecting up to 50 cancers. Grail seeks approval despite mixed trial results. Medicare coverage and insurance reimbursement hinge on FDA decision, potentially transforming early cancer detection.
FDA Panel Votes on First Multi-Cancer Blood Test
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →